Literature DB >> 16418198

Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.

C-H Jang1, J-H Choi, M-S Byun, D-M Jue.   

Abstract

OBJECTIVES: TNF-alpha, IL-1 and IL-6 are known to have primary roles in the pathogenesis of rheumatoid arthritis and other inflammatory diseases. The anti-rheumatic drug chloroquine has been shown to inhibit TNF-alpha, IL-1 and IL-6 production from mononuclear phagocytes. We examined the underlying mechanisms involved in the chloroquine-induced inhibition of cytokine production.
METHODS: Human peripheral blood mononuclear cells and monocytes/macrophages and monocytic U-937 and THP-1 cells were stimulated with lipopolysaccharide, and TNF-alpha, IL-1beta and IL-6 production was measured by ELISA. Levels of mRNA were measured by northern blotting and reverse transcription-polymerase chain reaction. Synthesis of 26-kDa TNF-alpha precursor was measured by metabolic labelling and immunoprecipitation analysis. Transcription rate was determined by nuclear run-on assay.
RESULTS: TNF-alpha release from the cells was inhibited by chloroquine, whereas the steady-state level of TNF-alpha mRNA and synthesis of 26-kDa TNF-alpha precursor were not changed by chloroquine. In contrast, chloroquine-induced inhibition of IL-1beta and IL-6 release was accompanied by a decrease in their steady-state mRNA levels. The transcription rates of the IL-1beta and IL-6 genes were not changed by chloroquine, whereas the stability of IL-1beta and IL-6 mRNA was decreased by chloroquine. Weak-base amines such as methylamine and ammonium chloride had no effect on the production of TNF-alpha, whereas they partially blocked the production of IL-1beta and IL-6.
CONCLUSIONS: Our results indicate that chloroquine-mediated inhibition of TNF-alpha, IL-1beta and IL-6 synthesis occurs through different modes in lipopolysaccharide-stimulated human monocytes/macrophages: it blocks the conversion of cell-associated TNF-alpha precursor to mature soluble protein, whereas it reduces the levels of IL-1beta and IL-6 mRNA, at least in part, by decreasing their stability and by a pH-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418198     DOI: 10.1093/rheumatology/kei282

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  103 in total

1.  Induction of autophagy is essential for monocyte-macrophage differentiation.

Authors:  Yan Zhang; Michael J Morgan; Kun Chen; Swati Choksi; Zheng-gang Liu
Journal:  Blood       Date:  2012-01-05       Impact factor: 22.113

Review 2.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

3.  Development of novel adenosine monophosphate-activated protein kinase activators.

Authors:  Jih-Hwa Guh; Wei-Ling Chang; Jian Yang; Su-Lin Lee; Shuo Wei; Dasheng Wang; Samuel K Kulp; Ching-Shih Chen
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

4.  Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems.

Authors:  Felipe T Lee-Montiel; Subin M George; Albert H Gough; Anup D Sharma; Juanfang Wu; Richard DeBiasio; Lawrence A Vernetti; D Lansing Taylor
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-14

5.  Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.

Authors:  Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2013-10-09       Impact factor: 4.932

6.  Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.

Authors:  Yuanzheng He; Yong Xu; Chenghai Zhang; Xiang Gao; Karl J Dykema; Katie R Martin; Jiyuan Ke; Eric A Hudson; Sok Kean Khoo; James H Resau; Arthur S Alberts; Jeffrey P MacKeigan; Kyle A Furge; H Eric Xu
Journal:  Sci Signal       Date:  2011-07-05       Impact factor: 8.192

Review 7.  New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

Authors:  Daniel J Wallace; Vineet S Gudsoorkar; Michael H Weisman; Swamy R Venuturupalli
Journal:  Nat Rev Rheumatol       Date:  2012-07-17       Impact factor: 20.543

8.  Escherichia coli flagellin stimulates pro-inflammatory immune response.

Authors:  Ayaid Khadem Zgair
Journal:  World J Microbiol Biotechnol       Date:  2012-02-12       Impact factor: 3.312

9.  Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Leticia Hachuel; Gabriela Boggio; Daniel Wojdyla; Virginia Pascual-Ramos; Enrique R Soriano; Verónica Saurit; Fernando S Cavalcanti; Renato A Guzman; Marlene Guibert-Toledano; Maria J Sauza Del Pozo; Mary-Carmen Amigo; Magaly Alva; Maria H Esteva-Spinetti; Bernardo A Pons-Estel
Journal:  Rheumatology (Oxford)       Date:  2012-03-02       Impact factor: 7.580

10.  A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.

Authors:  Vianney Tricou; Nguyet Nguyen Minh; Toi Pham Van; Sue J Lee; Jeremy Farrar; Bridget Wills; Hien Tinh Tran; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.